KRAS and colorectal cancer: Additionally, simvastatin resensitized patients with cetuximab-resistant KRAS-mutated colorectal cancer to cetuximab, and taking a statin after colorectal cancer diagnosis reduced the risk of death from colorectal cancer [27, 28].